coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Sheppey PCN, Swale · Health Inequalities Profile

    PCN U10128 · NHS Kent and Medway Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    48,666

    Registered population

    57.6% aged 18–64

    20.7%

    Aged 65+

    ICB 19.9% · England 17.9%

    5.3%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    53.1%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~23,415

    Core20 residents (est.)

    Resident basis; registered basis ~25,563 · see page 3

    8,508

    Hypertension register

    +2.91% in 3 yrs · England +5.60%

    393

    SMI register

    32.8% of Swale's

    1,375

    COPD register

    Reviews +4.86% in 3 yrs

    Forecast to 2030

    9,685

    Hypertension patients, 2030

    +1,177 on today

    81.0%

    QRISK ≥20% on statins, 2030

    +5.74pp over 3 yrs

    5.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    1,072
    Asthma review shortfall alongside high prescribing.

    Annual reviews fell 4.9% to 64.0% over 2023 to 2025 (England +4.4%), leaving 1,072 patients unreviewed while age 5-19 prescribing is 2,114 per 1,000.

    -4.1%
    Under-80 blood pressure control falling.

    Under-80 blood pressure control fell 4.1% (-3.0 pp) to 70.5% over 2023 to 2025 while England rose +3.2% (+2.1 pp), suggesting possible recall drift.

    +6.0%
    Older-adult BP and heart failure reviews.

    Over 2023 to 2025, 80+ blood pressure control rose +6.0% to 80.0% (England +2.2%) and heart failure reviews rose +17.1% to 75.1% (England +8.7%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Higher shares of children and older adults are consistent with dual-end primary care demand

    Sheppey PCN has 48,666 registered patients. Children aged 0–17 represent 21.8% (10,591 patients; Swale 22.0%, ICB 20.7%, England 19.6%) and adults aged 65+ represent 20.7% (10,056; Swale 18.2%, ICB 19.9%, England 17.9%), leaving 57.6% aged 18–64 (Swale 59.8%, ICB 59.5%, England 62.7%). Projected list growth to 2030 is 5.8% (Swale 5.5%, ICB 6.0%, England 2.3%) under an unverified method. On Census resident figures, not registered ethnicity, 94.7% are White (Swale 93.8%, ICB 88.6%, England 81.1%), with a 5.3% ethnic minority share and 0.7% Gypsy or Irish Traveller residents (Swale 0.6%, ICB 0.3%, England 0.1%).

    Age profile

    0–1721.8%
    18–6457.6%
    65+20.7%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White94.7%
    Mixed1.7%
    Black1.6%
    Asian1.4%
    Other0.5%

    Older people · falls rows are Swale local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Swale LA)1,4842,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Swale LA)6869819552024/25
    Falls deaths, all ages, per 100,000 (Swale LA)19.114.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 53.1%, spanning 32.8 percentage points between practices

    In Sheppey PCN, 53.1% of registered patients live in Core20 areas, exceeding Swale (25.7%), NHS Kent and Medway ICB (17.1%) and England (21.0%), with an average IMD decile of 2.8 (England 5.5). Weighted practice share is 52.5% (a 0.57 pp difference). Practice concentration spans 32.8 pp, led by St Georges Medical Centre (67.17%) and Sheerness Health Centre (61.4%). By volume, St Georges Medical Centre has 7,199 estimated Core20 patients, while Sheppey Healthy Living Centre holds 4,944 despite its lower 34.36% share, requiring dual-track targeting by concentration and scale.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    St Georges67.2% · 7,199 patients
    Sheerness61.4% · 4,122 patients
    Vel60.6% · 5,780 patients
    Om48.2% · 3,518 patients
    Sheppey Healthy34.4% · 4,944 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    393

    SMI register

    0.81% recorded prevalence

    375

    Learning disability register

    0.77% recorded prevalence

    14

    Care homes, 282 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Swale, Census 2021

    The PCN records 375 patients on its learning disability register (0.8% prevalence; Swale 0.8%, ICB 0.6%, England 0.6%) and 393 on its severe mental illness register (0.8%; Swale 0.8%, ICB 0.9%, England 1.0%). Catchment capacity covers 14 care homes with 282 beds.

    Severe mental illness: physical health checks

    Across 393 SMI register patients (0.8% prevalence vs England 1.0%), 12-month BMI checks fell 4.2 pp over 2023 to 2025 to 76.2% (England 82.1%, +5.1 pp), while blood pressure checks reached 80.7% (England 83.4%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,508

    Hypertension register

    +2.91%

    Register growth, 3 yrs

    Swale +5.38% · England +5.60%

    −3.02pp

    BP control, under 80

    ≤140/90 · +4.56pp aged 80+

    +1,177

    More patients by 2030

    Forecast 9,685 (18.47%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 17.4% (8,508 patients), compared with 17.0% in Swale, 16.2% in NHS Kent and Medway ICB and 15.2% in England, with register growth of +2.9% over 2023 to 2025 (England +5.6%). Blood pressure control in patients aged under 80 is 70.5% (England 67.8%), but fell 3.0 pp (relative change -4.1%; England +2.1 pp, +3.2%) over 2023 to 2025. For patients aged 80 and over, control rose +4.6 pp (+6.0%; England +1.8 pp, +2.2%) to 80.0% (England 81.2%). The three-year decline in under-80 control may reflect recall or treatment review intervals, which clinical audit would test.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid-lowering therapy reached 67.9%, above Swale (64.2%), NHS Kent and Medway ICB (61.4%) and England (63.6%), after rising +9.2% over 2023 to 2025 (England +6.2%). Favourable treatment rates provide an opportunity to review adherence across at-risk cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026111,707£2.10£1.90£1.86£234,585
    Cardiovascular (all), 2025132,495£2.10£3.57£3.33£278,240

    Lipid-regulating drugs cost £2.10 per item across 111,707 items in 2026, compared with £2.32 in Swale, £1.90 in NHS Kent and Medway ICB and £1.86 in England. The PCN spends £26,810 more than at England's unit cost. Unit-cost differences reflect formulary choice and do not establish prescribing efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −4.86%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.88%

    Asthma prevalence, PCN 3-yr % change

    Asthma prescribing for ages 5–19 is 2,114 items per 1,000 (England 1,488, Swale 1,582), while recorded reviews fell 4.9% over 2023 to 2025 to 64.0% (England 65.7%, +4.4%), leaving about 1,100 patients (1,072) unreviewed across the 2,977-patient register. COPD prevalence is 2.8% (1,375 patients; England 1.9%) with 80.6% reviewed in the last 12 months (England 76.4%). Higher paediatric prescribing alongside falling reviews may indicate reactive care, which clinical review audits could test.

    Cancer register and children's immunisation

    The cancer register records 2,010 patients (4.1% prevalence vs England 3.8%). In Q1 2025/26 COVER data, 6-in-1 at 24 months achieved 95.3% (England 92.2%), but age-5 second-dose MMR dropped to 85.5% despite 94.2% receiving MMR1, creating an 8.7 pp booster gap. At The Om Medical Centre, MMR2 trails MMR1 by 20 pp, and by 18.5 pp at Vel Surgery, showing that booster recall requires focused practice intervention.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.1%

    England 91.0%

    6-in-1 complete primary course at 24 months95.3%

    England 92.2%

    MMR dose 1 at 24 months88.4%

    England 88.3%

    MMR dose 2 at age 585.5%

    England 82.8%

    4-in-1 pre-school booster at age 584.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384 known-stage cases; England 55.3%), 19.4 pp below the 75.0% national ambition by 2028. Staging reflects system pathways rather than PCN performance; only 63.6% of 13,189 registered cancers had a known stage (England 67.0%). Reaching 75% requires 1,627 extra early-stage diagnoses across the ICB. Locally, PCN cervical screening is 70.5% (Swale 72.0%), trailing at The Om Medical Centre (61.2%), while breast screening is 67.9% (England 69.9%). Targeting screening recall at practices with lower uptake provides primary care's main lever to aid earlier detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional July 2026 data, Medway NHS Foundation Trust achieved 81.6% on the cancer 62-day referral to treatment standard, 3.4 pp below the 85.0% standard but above England (71.2%) and NHS Kent and Medway Integrated Care Board (75.9%), while Maidstone and Tunbridge Wells NHS Trust reached 87.4% and Mid and South Essex NHS Foundation Trust recorded 50.2%. Medway met the 75.0% 28-day faster diagnosis standard at 77.8% (ICB 76.8%, England 79.3%) and the 96.0% 31-day standard at 99.6% (ICB 95.8%, England 92.5%). Diagnostic 6+ week waits at Medway were 0.7% for MRI and 0.0% for CT.

    Pathways within standard (%)MedwayMid and South EssexMaidstone and Tunbridge WellsKent and Medway ICBEngland
    28-day faster diagnosis (75%)77.7767.4581.7876.7879.32
    31-day treatment (96%)99.6281.8898.3595.8492.50
    62-day referral to treatment (85%)81.6450.2587.4375.9371.16
    Diagnostic waits over 6 weeks (%)MedwayMid and South EssexMaidstone and Tunbridge WellsEngland
    MRI0.6823.350.9221.40
    CT0.006.070.519.92
    Echocardiography36.6265.052.5728.48
    Colonoscopy1.8864.0919.8030.83
    Gastroscopy3.3259.7624.0329.02
    All 15 DM01 tests14.2041.546.4223.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In provisional June 2026 figures, adults aged 65 and over accounted for 65.8% of all community contacts among Swale borough residents (138,250 of 210,170 contacts). These resident figures describe wider community service activity rather than PCN-specific delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Vel Surgery11160.684.8%82.0%89.0%
    Sheppey Healthy11334.432.3%66.5%71.5%
    Om11048.250.8%65.6%65.1%
    St Georges10767.221.6%68.8%62.7%
    Sheerness9761.428.1%73.8%58.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSwaleAssetPCNSwale
    Care homes (catchment)14 (282 beds)n/aSchools (catchment)25n/a
    Children's centres410Places of worship1270
    Libraries25Food banks (VCS)15
    Day centres (VCS)89Children and young people (VCS)320
    Carers support groups (VCS)n/a1Primary schools (LA maintained)215
    Primary academies831Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and inhaler recall

    Asthma reviews reached 64.0% of 2,977 patients (Swale 63.4%, England 65.7%), falling 4.9% (3.3 pp) over 2023 to 2025 (England +4.4%, +2.8 pp) and leaving 1,072 unreviewed alongside 2,114 items per 1,000 aged 5-19 (England 1,488). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Under-80 hypertension recall and titration review

    Across 8,508 hypertensive patients, under-80 BP control is 70.5% (Swale 67.8%, England 67.8%) but fell 4.1% (3.0 pp) over 2023 to 2025 (England +3.2%, +2.1 pp); recent readings are 87.8% (down 0.6%; England 90.0%, +3.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Dementia register coding and case-finding audit

    Dementia recorded prevalence is 0.6% (290 patients) against 0.7% in Swale and 0.8% in ICB and England, falling 1.7% over 2023 to 2025 (Swale +2.4%, England +6.0%), giving a crude benchmark range of +50 to +91 patients. Low cost, quick to run.

    Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.

    Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Inclusion health and dual-track planning (p2)Gypsy or Irish TravellerNeighbourhood health framework · Core20PLUS5 approachPCN
    Dual-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Under-eighty blood pressure recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review and inhaler recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 2 · Under-80 hypertension recall and titration review (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Dementia register coding and case-finding audit (p12)Dementia register · Dementia: QOF prevalence · Aged 65+66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15